AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 297: H1685-H1696, 2009. First published September 4, 2009; doi:10.1152/ajpheart.00015.2009
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
297/5/H1685    most recent
00015.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Onimaru, M.
Right arrow Articles by Sueishi, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onimaru, M.
Right arrow Articles by Sueishi, K.

VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B

Mitsuho Onimaru,1,* Yoshikazu Yonemitsu,1,* Takaaki Fujii,1 Mitsugu Tanii,1 Toshiaki Nakano,1 Kazunori Nakagawa,1 Ri-ichiro Kohno,1 Mamoru Hasegawa,2 Shin-ichi Nishikawa,3 and Katsuo Sueishi1

1Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka; 2DNAVEC Corporation, Tsukuba, Ibaraki; and 3Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology, Kobe, Hyogo, Japan

Submitted January 7, 2009 ; accepted in final form September 4, 2009

Emerging evidence indicates that the tight communication between vascular endothelial cells and mural cells using platelet-derived growth factor (PDGF)-BB is essential for capillary stabilization during the angiogenic process. However, little is known about the related regulator that determines PDGF-BB expression. Using murine models of therapeutic neovascularization, we here show that a typical lymphangiogenic factor, vascular endothelial growth factor (VEGF)-C, is an essential regulator determining PDGF-BB expression for vascular stabilization via a paracrine mode of action. The blockade of VEGF type 3 receptor (VEGFR3) using neutralizing antibody AFL-4 abrogated FGF-2-mediated limb salvage and blood flow recovery in severely ischemic hindlimb. Interestingly, inhibition of VEGFR3 activity not only diminished lymphangiogenesis, but induced marked dilatation of capillary vessels, showing mural cell dissociation. In these mice, VEGF-C and PDGF-B were upregulated in the later phase after induced ischemia, on day 7, when exogenous FGF-2 expression had already declined, and blockade of VEGFR3 or PDGF-BB activities diminished PDGF-B or VEGF-C expression, respectively. These results clearly indicate that VEGF-C is a critical mediator, not only for lymphangiogenesis, but also for capillary stabilization, the essential molecular mechanism of communication between endothelial cells and mural cells during neovascularization.

vascular endothelial growth factor-C; platelet-derived growth factor-BB; lymphangiogenesis; capillary stabilization



Address for reprint requests and other correspondence: Y. Yonemitsu, Division of Pathophysiological and Experimental Pathology, Dept. of Pathology, Graduate School of Medical Sciences, Kyushu Univ., 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan (e-mail: yonemitu{at}med.kyushu-u.ac.jp).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.